These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 19706115

  • 1. Successful management of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using vincristine and ticlopidine.
    López V, Martí N, Pereda C, Martín JM, Ramón D, Mayordomo E, Jordá E.
    Pediatr Dermatol; 2009; 26(3):365-6. PubMed ID: 19706115
    [Abstract] [Full Text] [Related]

  • 2. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
    Hermans DJ, van Beynum IM, van der Vijver RJ, Kool LJ, de Blaauw I, van der Vleuten CJ.
    J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018
    [Abstract] [Full Text] [Related]

  • 3. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
    Garcia-Monaco R, Giachetti A, Peralta O, Napoli N, Lobos P, Gioseffi L, Mariani G.
    J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299
    [Abstract] [Full Text] [Related]

  • 4. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
    Jahnel J, Lackner H, Reiterer F, Urlesberger B, Urban C.
    Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
    [No Abstract] [Full Text] [Related]

  • 5. Vincristine and corticosteroids as first-line treatment of Kasabach-Merritt syndrome in kaposiform hemangioendothelioma.
    Drucker AM, Pope E, Mahant S, Weinstein M.
    J Cutan Med Surg; 2009 Oct; 13(3):155-9. PubMed ID: 19426625
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
    Fernandez-Pineda I, Lopez-Gutierrez JC, Chocarro G, Bernabeu-Wittel J, Ramirez-Villar GL.
    Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
    [Abstract] [Full Text] [Related]

  • 7. Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using alpha-interferon.
    Harper L, Michel JL, Enjolras O, Raynaud-Mounet N, Rivière JP, Heigele T, De Napoli-Cocci S.
    Eur J Pediatr Surg; 2006 Oct; 16(5):369-72. PubMed ID: 17160787
    [Abstract] [Full Text] [Related]

  • 8. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen.
    Hauer J, Graubner U, Konstantopoulos N, Schmidt S, Pfluger T, Schmid I.
    Pediatr Blood Cancer; 2007 Nov; 49(6):852-4. PubMed ID: 16411198
    [Abstract] [Full Text] [Related]

  • 9. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J, Smink GM, Helm K, Xavier F.
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [Abstract] [Full Text] [Related]

  • 10. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine.
    Barabash-Neila R, García-Rodríguez E, Bernabeu-Wittel J, Bueno-Rodríguez I, Ramírez-Villar G, López-Gutierrez JC.
    Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581
    [No Abstract] [Full Text] [Related]

  • 11. Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.
    Fernandez-Pineda I, Lopez-Gutierrez JC, Ramirez G, Marquez C.
    Pediatr Hematol Oncol; 2010 Nov; 27(8):641-5. PubMed ID: 20863161
    [Abstract] [Full Text] [Related]

  • 12. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
    Wang Y, Kong L, Sun B, Cui J, Shen W.
    J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
    [Abstract] [Full Text] [Related]

  • 13. Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.
    Rodriguez V, Lee A, Witman PM, Anderson PA.
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):522-6. PubMed ID: 19564750
    [Abstract] [Full Text] [Related]

  • 14. Mediastinal Kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in an infant: treatment with interferon.
    Hartman KR, Moncur JT, Minniti CP, Creamer KM.
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):690-2. PubMed ID: 19687760
    [Abstract] [Full Text] [Related]

  • 15. [Kasabach-Merritt syndrome on a congenital tufted angioma].
    Enjolras O, Wassef M, Dosquet C, Drouet L, Fortier G, Josset P, Merland JJ, Escande JP.
    Ann Dermatol Venereol; 1998 Apr; 125(4):257-60. PubMed ID: 9747263
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon.
    Deb G, Jenkner A, De Sio L, Boldrini R, Bosman C, Standoli N, Donfrancesco A.
    Med Pediatr Oncol; 1997 May; 28(5):358-61. PubMed ID: 9121401
    [Abstract] [Full Text] [Related]

  • 20. Successful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine.
    Fahrtash F, McCahon E, Arbuckle S.
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):506-10. PubMed ID: 20523249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.